Atlas Venture Fund XI, L.P. - 30 Mar 2021 Form 4 Insider Report for Ikena Oncology, Inc. (IKNA)

Role
10%+ Owner
Signature
Atlas Venture Fund XI, L.P., By: Atlas Venture Associates XI, L.P., its general partner, By: Atlas Venture Associates XI, LLC, its general partner, By: Ommer Chohan, Chief Financial Officer /s/ Ommer Chohan
Issuer symbol
IKNA
Transactions as of
30 Mar 2021
Transactions value $
$1,614,428
Form type
4
Filing time
14 Dec 2021, 19:27:43 UTC
Previous filing
02 Jun 2021
Next filing
26 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IKNA Common Stock Purchase $2M +125K +16.67% $16.00 875K 30 Mar 2021 See footnote F1
transaction IKNA Common Stock Sale -$180K -12K -0.95% $15.03 1.26M 10 Dec 2021 Direct F2, F3
transaction IKNA Common Stock Sale -$122K -8.33K -0.66% $14.64 1.25M 13 Dec 2021 Direct F3, F4
transaction IKNA Common Stock Sale -$83.4K -5.96K -0.48% $14.00 1.24M 14 Dec 2021 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Venture Opportunity Fund I"). The general partner of Atlas Venture Opportunity Fund I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. Each of AVAO I LP and AVAO I LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Opportunity Fund I, except to the extent of its pecuniary interest therein, if any.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.60 to $15.55 inclusive. The Reporting Persons undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4).
F3 The shares are held directly by Atlas Venture Fund XI, L.P. ("Atlas Venture Fund XI"). The general partner of Atlas Venture Fund XI is Atlas Venture Associates XI, L.P. ("AVA XI LP"). Atlas Venture Associates XI, LLC ("AVA XI LLC") is the general partner of AVA XI LP. Each of AVA XI LP and AVA XI LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund XI, except to the extent of its pecuniary interest therein, if any.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.60 to $14.65 inclusive.